SUCNR1 (Succinate Receptor 1)

G protein-coupled receptor for succinate; roles in metabolism, inflammation, and hypertension

Gene Information Card

Symbol SUCNR1
Full Name Succinate Receptor 1
Gene Type protein-coding
Chromosomal Location 3q25.1
NCBI Gene ID 56670 ncbi.nlm.nih.gov/gene/56670
Ensembl ID ENSG00000198829
UniProt ID Q9BXA5
OMIM ID 606381
HGNC ID 17810
Aliases GPR91, P2RY13

Description

SUCNR1 (Succinate Receptor 1) encodes a G protein-coupled receptor (GPCR) that binds extracellular succinate, a tricarboxylic acid cycle intermediate. Activation of SUCNR1 triggers intracellular signaling via Gq/11 and Gi/o proteins, leading to calcium mobilization and MAPK pathway activation. The receptor is involved in metabolic regulation, inflammatory responses, blood pressure control, and cellular stress sensing. It is expressed in kidney, liver, adipose tissue, immune cells, and retina.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hypertension Succinate-mediated SUCNR1 activation in renal juxtaglomerular cells stimulates renin release, increasing blood pressure. PMID: 18614766
Obesity and insulin resistance SUCNR1 signaling in adipose tissue promotes adipogenesis and modulates glucose homeostasis; altered expression linked to metabolic syndrome. PMID: 23505218
Inflammatory bowel disease (IBD) Succinate activates SUCNR1 on immune cells (dendritic cells, macrophages) to produce pro-inflammatory cytokines, exacerbating colitis. PMID: 28068329
Retinal ischemia SUCNR1 activation in retinal ganglion cells contributes to excitotoxicity and neuronal damage during ischemic stress. PMID: 20018723
Rheumatoid arthritis Succinate accumulation in inflamed joints activates SUCNR1 on synovial fibroblasts, promoting IL-1β production and joint destruction. PMID: 28104835

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 8.2 High
Liver 5.1 Medium
Adipose tissue 4.8 Medium
Spleen 3.9 Medium
Lung 2.5 Low
Retina 6.7 High
Small intestine 3.2 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 12.5 Overexpressed in recombinant studies
THP-1 (monocytes) 7.8 Endogenous expression
HepG2 (hepatocytes) 4.3 Moderate expression
3T3-L1 (adipocytes) 6.1 Differentiation-dependent
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.119G>A (p.Arg40His) Missense <0.01% Reduced succinate binding affinity in vitro
c.556C>T (p.Arg186Trp) Missense <0.01% Impaired G protein coupling
c.832G>A (p.Gly278Ser) Missense <0.01% Altered receptor trafficking
Mutation functional classification

Loss of Function (LOF)

p.Arg40His and p.Arg186Trp reduce ligand binding or signaling.

Gain of Function (GOF)

No confirmed gain-of-function variants reported.

Dominant Negative (DN)

Not described for SUCNR1.

Pathways

• Succinate signaling via SUCNR1 (Reactome: R-HSA-418594)
• GPCR downstream signaling (Reactome: R-HSA-388396)
• Renin-angiotensin system (KEGG: hsa04614)

Protein Summary

SUCNR1 (also known as GPR91) is a 330-amino acid G protein-coupled receptor with seven transmembrane domains. It is activated by extracellular succinate at micromolar concentrations. The receptor couples primarily to Gq/11, leading to phospholipase C activation and intracellular calcium release, and to Gi/o, inhibiting cAMP production. SUCNR1 is expressed in kidney, liver, adipose tissue, immune cells, and retina, where it mediates metabolic, inflammatory, and cardiovascular functions. Structural studies reveal a binding pocket for succinate involving residues Arg99, Arg252, and His103. The receptor is a target for therapeutic intervention in hypertension, metabolic disorders, and inflammatory diseases.

Related Products

Product name Cat.No. Species Gene ID
SUCNR1 Knockout A-549 Cell Line EDJ-KQ65252 Human 56670 Details Get a Quote
SUCNR1 Knockout HeLa Cell Line EDJ-KQ56749 Human 56670 Details Get a Quote
SUCNR1 Knockout HCT 116 Cell Line EDJ-KQ17950 Human 56670 Details Get a Quote
SUCNR1 Knockout HEK293 Cell Line EDJ-KQ1796 Human 56670 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: